-
10/10 Research Claims Herbalife May Be Attached To Brazilian Money-Laundering Complaint
Monday, October 24, 2016 - 12:06pm | 363Read More...An unsubstantiated post about Herbalife Ltd. (NYSE: HLF) alleged the company could be in deep trouble for money-laundering and drug trade. In a post on Zero Hedge, user 10/10 Research said critics have been charging Herbalife for years of having a fraud layer akin to a pyramid scheme. The...
-
Pivotal's Ramey Pounds Table On Herbalife
Saturday, May 7, 2016 - 2:07pm | 170Read More...Pivotal Research analyst Tim Ramey, who has a Buy rating on Herbalife Ltd. (NYSE: HLF) shares, maintains that the company would have injunction or consent decree as part of its potential settlement with FTC. "We clearly are moving forward to something …it could be litigation we can take that off...
-
New Document Shows Pershing Square Could Be Under SEC Investigation For Herbalife 'Manipulation'
Thursday, September 17, 2015 - 2:03pm | 356Read More...Pershing Square could be under an SEC investigation for alleged stock manipulation. The investigation may stem from the hedge fund's short thesis in Herbalife Ltd. (NYSE: HLF). Tim Ramey of Pivotal Research believes an SEC investigation began at some point between July 7 and September 15....
-
Pivotal Analyst On Herbalife–Vemma Comparison: Ackman 'Grasping At Straws'
Tuesday, September 15, 2015 - 1:44pm | 520Read More...Shares of Herbalife Ltd. (NYSE: HLF) traded higher on Tuesday despite a letter from Pershing Square comparing the company to Vemma Nutrition. Vemma Nutrition was shut down by the FTC for operating a pyramid scheme late last month. Pivotal Research's Tim Ramey told Benzinga that Ackman...
-
Analyst Sees Herbalife as 'Single Best Idea' in 2014
Thursday, January 2, 2014 - 11:18am | 157Read More...In a report published Thursday, D.A. Davidson & Co. analyst Tim Ramey maintained a Buy rating on Herbalife (NYSE: HLF), keeping its $115.00 price target. “The company has had two big-four audits, both with a clean bill of health. The second, by PwC, with particular attention and inquiry...
-
UPDATE: D.A. Davidson Downgraded Nu Skin Enterprises to Neutral as Shares Close on Target
Friday, September 13, 2013 - 11:11am | 214Read More...D.A. Davidson analyst Tim Ramey downgraded the rating on Nu Skin Enterprises (NYSE: NUS) from Buy to Neutral. In the report, D.A. Davidson noted, “We are reducing our rating on Nu Skin to NEUTRAL, previously Buy. Our Buy rating dates back to May 3rd 2006 with the stock at $14.75. The shares now...
-
D.A. Davidson Reiterates Underperform Rating on Flowers Foods Following Strong Q2 EPS Report
Wednesday, August 14, 2013 - 9:42am | 211Read More...In a report published Wednesday, D.A. Davidson analyst Tim Ramey reiterated an Underperform rating and $12.00 price target on Flowers Foods (NYSE: FLO). In the report, D.A. Davidson noted, “Q2 operating EPS of $0.24 increased 63.7% from $0.14 last year and was a penny better than our Street-...
-
UPDATE: D.A. Davidson Raises PT on USANA Health Sciences Following Q2 EPS Report
Wednesday, July 24, 2013 - 9:26am | 171Read More...In a report published Wednesday, D.A. Davidson analyst Tim Ramey reiterated a Neutral rating on USANA Health Sciences (NYSE: USNA), and raised the price target from $80.00 to $92.00. In the report, D.A. Davidson noted, “Q2 operating EPS of $1.72 was up ~55% from $1.11 last year, exceeding our $...
-
UPDATE: D.A. Davidson Lowers PT on Flowers Foods Following Stock Split
Tuesday, June 25, 2013 - 9:29am | 166Read More...In a report published Tuesday, D.A. Davidson analyst Tim Ramey reiterated an Underperform rating on Flowers Foods (NYSE: FLO), but lowered the price target from $18.00 to $12.00. In the report, D.A. Davidson noted, “We have adjusted our price targets and earnings estimates to account for the 3:...
-
UPDATE: D.A. Davidson Downgrades USANA Health Sciences to Neutral on Valuation
Friday, May 31, 2013 - 8:57am | 168Read More...In a report published Friday, D.A. Davidson analyst Tim Ramey downgraded the rating on USANA Health Sciences (NYSE: USNA) from Buy to Neutral, but reiterated the $80.00 price target. In the report, D.A. Davidson noted, “We are downgrading USNA shares to NEUTRAL, previously Buy, given the...
-
UPDATE: D.A. Davidson Raises PT on Smithfield Foods Following Shuanghui International Agreement
Thursday, May 30, 2013 - 10:01am | 224Read More...In a report published Thursday, D.A. Davidson analyst Tim Ramey reiterated a Buy rating on Smithfield Foods (NYSE: SFD), and raised the price target from $32.00 to $38.00. In the report, D.A. Davidson noted, “China-based Shuanghui International Holdings Limited agrees to acquire all of SFD's...
-
Analyst Ramey Appears on CNBC to Talk Herbalife; CNBC's Herb Greenberg Skeptical
Tuesday, March 6, 2012 - 3:31pm | 791Read More...Earlier on CNBC, analyst Tim Ramey appeared on the network to discuss Herbalife (NYSE: HLF). Previously, CNBC's Herb Greenberg had raised some questions about the company on Fast Money and in a post on CNBC.com. Ramey called the company high quality with tremendous growth potential. He stated that...
